Is There a causal relation between maternal acetaminophen administration and ADHD?

Antonio Saad, Shruti Hegde, Talar Kechichian, Phyllis Gamble, Mahbubur Rahman, Sonja J. Stutz, Noelle C. Anastasio, Wael Alshehri, Jun Lei, Susumu Mori, Bridget Kajs, Kathryn A. Cunningham, George Saade, Irina Burd, Maged Costantine

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective Recent epidemiological studies reported an association between maternal intake of acetaminophen (APAP) and attention deficit hyperactivity disorder (ADHD) in their children. However, none of these studies demonstrated causality. Our objective was to determine whether exposure to APAP during pregnancy result in hyperkinetic dysfunctions in offspring, using a murine model. Material and Methods Pregnant CD1 mice (N = 8/group) were allocated to receive by gavage either APAP (150 mg/kg/day, equivalent to the FDA-approved maximum human clinical dose), or 0.5% carboxymethylcellulose (control group), starting on embryonic day 7 until delivery. Maternal serum APAP and alanine transaminase (ALT) concentrations were determined by ELISA and kinetic colorimetric assays, respectively. Open field locomotor activity (LMA) in the 30-day old mouse offspring was quantified using Photobeam Activity System. Mouse offspring were then sacrificed, whole brains processed for magnetic resonance imaging (MRI; 11.7 Tesla magnet) and for neuronal quantification using Nissl stain. The association between APAP exposure and LMA in mouse offspring was analyzed using a mixed effects Poisson regression model that accounted for mouse offspring weight, gender, random selection, and testing time and day. We corrected for multiple comparisons and considered P

Original languageEnglish (US)
Article numbere0157380
JournalPLoS One
Volume11
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

acetaminophen
Attention Deficit Disorder with Hyperactivity
Acetaminophen
Mothers
mice
locomotion
animal models
Locomotion
carboxymethylcellulose
alanine transaminase
magnetic resonance imaging
Association reactions
epidemiological studies
Carboxymethylcellulose Sodium
Magnets
enzyme-linked immunosorbent assay
pregnancy
Magnetic resonance
Alanine Transaminase
brain

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Saad, A., Hegde, S., Kechichian, T., Gamble, P., Rahman, M., Stutz, S. J., ... Costantine, M. (2016). Is There a causal relation between maternal acetaminophen administration and ADHD? PLoS One, 11(6), [e0157380]. https://doi.org/10.1371/journal.pone.0157380

Is There a causal relation between maternal acetaminophen administration and ADHD? / Saad, Antonio; Hegde, Shruti; Kechichian, Talar; Gamble, Phyllis; Rahman, Mahbubur; Stutz, Sonja J.; Anastasio, Noelle C.; Alshehri, Wael; Lei, Jun; Mori, Susumu; Kajs, Bridget; Cunningham, Kathryn A.; Saade, George; Burd, Irina; Costantine, Maged.

In: PLoS One, Vol. 11, No. 6, e0157380, 01.06.2016.

Research output: Contribution to journalArticle

Saad, A, Hegde, S, Kechichian, T, Gamble, P, Rahman, M, Stutz, SJ, Anastasio, NC, Alshehri, W, Lei, J, Mori, S, Kajs, B, Cunningham, KA, Saade, G, Burd, I & Costantine, M 2016, 'Is There a causal relation between maternal acetaminophen administration and ADHD?', PLoS One, vol. 11, no. 6, e0157380. https://doi.org/10.1371/journal.pone.0157380
Saad, Antonio ; Hegde, Shruti ; Kechichian, Talar ; Gamble, Phyllis ; Rahman, Mahbubur ; Stutz, Sonja J. ; Anastasio, Noelle C. ; Alshehri, Wael ; Lei, Jun ; Mori, Susumu ; Kajs, Bridget ; Cunningham, Kathryn A. ; Saade, George ; Burd, Irina ; Costantine, Maged. / Is There a causal relation between maternal acetaminophen administration and ADHD?. In: PLoS One. 2016 ; Vol. 11, No. 6.
@article{eafa14278ea645069c6a525a3edbf951,
title = "Is There a causal relation between maternal acetaminophen administration and ADHD?",
abstract = "Objective Recent epidemiological studies reported an association between maternal intake of acetaminophen (APAP) and attention deficit hyperactivity disorder (ADHD) in their children. However, none of these studies demonstrated causality. Our objective was to determine whether exposure to APAP during pregnancy result in hyperkinetic dysfunctions in offspring, using a murine model. Material and Methods Pregnant CD1 mice (N = 8/group) were allocated to receive by gavage either APAP (150 mg/kg/day, equivalent to the FDA-approved maximum human clinical dose), or 0.5{\%} carboxymethylcellulose (control group), starting on embryonic day 7 until delivery. Maternal serum APAP and alanine transaminase (ALT) concentrations were determined by ELISA and kinetic colorimetric assays, respectively. Open field locomotor activity (LMA) in the 30-day old mouse offspring was quantified using Photobeam Activity System. Mouse offspring were then sacrificed, whole brains processed for magnetic resonance imaging (MRI; 11.7 Tesla magnet) and for neuronal quantification using Nissl stain. The association between APAP exposure and LMA in mouse offspring was analyzed using a mixed effects Poisson regression model that accounted for mouse offspring weight, gender, random selection, and testing time and day. We corrected for multiple comparisons and considered P",
author = "Antonio Saad and Shruti Hegde and Talar Kechichian and Phyllis Gamble and Mahbubur Rahman and Stutz, {Sonja J.} and Anastasio, {Noelle C.} and Wael Alshehri and Jun Lei and Susumu Mori and Bridget Kajs and Cunningham, {Kathryn A.} and George Saade and Irina Burd and Maged Costantine",
year = "2016",
month = "6",
day = "1",
doi = "10.1371/journal.pone.0157380",
language = "English (US)",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - Is There a causal relation between maternal acetaminophen administration and ADHD?

AU - Saad, Antonio

AU - Hegde, Shruti

AU - Kechichian, Talar

AU - Gamble, Phyllis

AU - Rahman, Mahbubur

AU - Stutz, Sonja J.

AU - Anastasio, Noelle C.

AU - Alshehri, Wael

AU - Lei, Jun

AU - Mori, Susumu

AU - Kajs, Bridget

AU - Cunningham, Kathryn A.

AU - Saade, George

AU - Burd, Irina

AU - Costantine, Maged

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Objective Recent epidemiological studies reported an association between maternal intake of acetaminophen (APAP) and attention deficit hyperactivity disorder (ADHD) in their children. However, none of these studies demonstrated causality. Our objective was to determine whether exposure to APAP during pregnancy result in hyperkinetic dysfunctions in offspring, using a murine model. Material and Methods Pregnant CD1 mice (N = 8/group) were allocated to receive by gavage either APAP (150 mg/kg/day, equivalent to the FDA-approved maximum human clinical dose), or 0.5% carboxymethylcellulose (control group), starting on embryonic day 7 until delivery. Maternal serum APAP and alanine transaminase (ALT) concentrations were determined by ELISA and kinetic colorimetric assays, respectively. Open field locomotor activity (LMA) in the 30-day old mouse offspring was quantified using Photobeam Activity System. Mouse offspring were then sacrificed, whole brains processed for magnetic resonance imaging (MRI; 11.7 Tesla magnet) and for neuronal quantification using Nissl stain. The association between APAP exposure and LMA in mouse offspring was analyzed using a mixed effects Poisson regression model that accounted for mouse offspring weight, gender, random selection, and testing time and day. We corrected for multiple comparisons and considered P

AB - Objective Recent epidemiological studies reported an association between maternal intake of acetaminophen (APAP) and attention deficit hyperactivity disorder (ADHD) in their children. However, none of these studies demonstrated causality. Our objective was to determine whether exposure to APAP during pregnancy result in hyperkinetic dysfunctions in offspring, using a murine model. Material and Methods Pregnant CD1 mice (N = 8/group) were allocated to receive by gavage either APAP (150 mg/kg/day, equivalent to the FDA-approved maximum human clinical dose), or 0.5% carboxymethylcellulose (control group), starting on embryonic day 7 until delivery. Maternal serum APAP and alanine transaminase (ALT) concentrations were determined by ELISA and kinetic colorimetric assays, respectively. Open field locomotor activity (LMA) in the 30-day old mouse offspring was quantified using Photobeam Activity System. Mouse offspring were then sacrificed, whole brains processed for magnetic resonance imaging (MRI; 11.7 Tesla magnet) and for neuronal quantification using Nissl stain. The association between APAP exposure and LMA in mouse offspring was analyzed using a mixed effects Poisson regression model that accounted for mouse offspring weight, gender, random selection, and testing time and day. We corrected for multiple comparisons and considered P

UR - http://www.scopus.com/inward/record.url?scp=84976354750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976354750&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0157380

DO - 10.1371/journal.pone.0157380

M3 - Article

C2 - 27295086

AN - SCOPUS:84976354750

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 6

M1 - e0157380

ER -